Thomas Watkins

Insider Reports History

Entity
Individual
Location
1221 Gulf Shore Blvd N #303, Naples, FL
Signature
/s/ Patrick McIlvenny, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas Watkins:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Vanda Pharmaceuticals Inc. Director Common Stock 63.1K $368K $5.84 Jun 2, 2022 Direct
Horizon Therapeutics Public Ltd Co Director Ordinary Shares 0 $116.50 Oct 6, 2023 By Family Limited Partnership
Horizon Therapeutics Public Ltd Co Director Ordinary Shares 0 $116.50 Oct 6, 2023 By Trust
Horizon Therapeutics Public Ltd Co Director Ordinary Shares 0 $116.50 Oct 6, 2023 Direct
Horizon Therapeutics Public Ltd Co Director Restricted Stock Units 0 Oct 6, 2023 Direct
Horizon Therapeutics Public Ltd Co Director Stock Option (Right to Buy) 0 Oct 6, 2023 Direct
Vanda Pharmaceuticals Inc. Director Stock Option (Right to Buy) 0 Jun 2, 2022 Direct

Insider Reports Filed by Thomas Watkins

Symbol Company Period Transactions Value $ Form Type Date Filed Role
HZNP Horizon Therapeutics Public Ltd Co Oct 6, 2023 8 -$20.6M 4 Oct 6, 2023 Director
HZNP Horizon Therapeutics Public Ltd Co Sep 29, 2023 6 $1.11M 4 Oct 2, 2023 Director
HZNP Horizon Therapeutics Public Ltd Co Jul 27, 2023 1 $0 4 Jul 28, 2023 Director
HZNP Horizon Therapeutics Public Ltd Co Apr 28, 2023 2 $0 4 May 2, 2023 Director
VNDA Vanda Pharmaceuticals Inc. Jun 2, 2022 3 -$1.53K 4 Jun 3, 2022 Director
HZNP Horizon Therapeutics Public Ltd Co Apr 28, 2022 3 $0 4 May 2, 2022 Director
VNDA Vanda Pharmaceuticals Inc. Jun 10, 2021 2 $0 4 Jun 14, 2021 Director